Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Finland

This page shows the latest Finland news and features for those working in and with pharma, biotech and healthcare.

UK confirms first cases of coronavirus as global concerns mount

UK confirms first cases of coronavirus as global concerns mount

There have been 98 cases in upwards of 18 other countries, including the Australia, Canada, France, Finland, Germany, India Japan, the US and Vietnam, and it was almost inevitable that the

Latest news

  • Resurgent Diurnal raises £5.4m for twin product filings Resurgent Diurnal raises £5.4m for twin product filings

    In March, Diurnal also signed its first partnership for Alkindi with Swedish group Anthrop Pharmaceuticals, which covers the commercialisation of the drug in Sweden, Norway, Denmark, Finland and Iceland, a

  • Big opportunities in big data, but EMA and industry just getting started Big opportunities in big data, but EMA and industry just getting started

    Co-chair Nikolai Brun. The task force is made up of representatives from the national medical agencies from Germany, Denmark, Estonia, Finland, Hungary, Ireland the Netherlands and the UK, and the

  • GSK and Sanofi join Finland's 500,000 genomics study GSK and Sanofi join Finland's 500,000 genomics study

    The size of the study means its target represents nearly 10% of Finland’s entire population of 5.5m. ... The project is expected to continue for ten years and has a current budget of 59m, with the funding coming from pharmaceutical companies and

  • Bayer preps filings for new prostate cancer drug Bayer preps filings for new prostate cancer drug

    Bayer, which co-develops darolutamide with Finland’s Orion Pharma under the terms of a 2014 licensing deal, says it will discuss the data from ARAMIS with regulatory authorities to see

  • Daily Brief Daily Brief

    The Finland-based, London-listed company is developing the drug for acute respiratory distress syndrome (ARDS), a rare but often fatal inflammation of the lungs, which had been tipped for great

More from news
Approximately 1 fully matching, plus 66 partially matching documents found.

Latest Intelligence

  • The true potential of mobile health tech The true potential of mobile health tech

    In Finland, the government is releasing citizens’ well-being records to professionals and researchers to boost outcomes and energise the nation’s preventative health strategy.

  • A rare talent A rare talent

    Prior to this he held a number of roles at Astellas, most recently as specialty care director for the UK business, and country manager, for Finland, where he established the ... Finland was an amazing experience. On a personal level, I enjoyed my two

  • Safe from harm? Safe from harm?

    In Germany (75%), Austria (71%), Canada (66%), Finland (65%) and the US (64%), patients were most likely to work with the physician so that both of them have input into decision.

  • A rising tide A rising tide

    And it's not just Germany - the UK is also ranked mid-table behind Finland, France, Latvia, Sweden and the Netherlands when it comes to the share of women on the

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    Pharma interview: Anssi Pulkkinen from Roche Diagnostics, Finland on the increasing prominence of diagnostics. ... One man who is able to see this change of attitude in action is Anssi Pulkkinen, head of strategic marketing at Roche Diagnostics Finland -

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....

Quick links